# Cell-free DNA sequencing to screen for and tell apart seven common cancers (Air Force Military Medical University)

Source: https://onco.cc/trials/xijing-cfdna-seven-cancers/  
OnCo record `xijing-cfdna-seven-cancers` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Chinese study of 3,200 people testing whether a DNA sequencing blood test can detect seven common cancers and tell them apart.

## Summary

Cell-free DNA sequencing to screen for and tell apart seven common cancers (NCT06036563) is an observational study sponsored by Air Force Military Medical University, China with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Tang-Du Hospital, The First Affiliated Hospital of Guangzhou Medical University and others. It asks whether a model based on peripheral blood cell-free DNA sequencing can screen for and classify seven common cancers, especially at early stages.

The registry record, read on 29 October 2026, gives its status as unknown (the sponsor last updated it on 16 May 2024), with an estimated 3,200 participants, a start on 1 September 2023 and primary completion expected in August 2025.

## Fields

- Kind: Trial
- Last checked: 2026-10-29
- Registry id: NCT06036563
- Phase: observational
- Setting: Adults with or without suspicious lesions at eight Chinese centres, testing a cell-free DNA sequencing model for lung, stomach, colorectal, oesophageal, liver, breast and pancreatic cancer
- Sponsor: Air Force Military Medical University, China with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Tang-Du Hospital, The First Affiliated Hospital of Guangzhou Medical University, First Hospital of China Medical University, People's Hospital of Ningxia Hui Autonomous Region, Xinjiang Medical University, Guanxian County People's Hospital
- Enrolled: 3200

## Sources

- ClinicalTrials.gov NCT06036563: https://clinicaltrials.gov/study/NCT06036563

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)

---
JSON: https://onco.cc/api/v1/entities/xijing-cfdna-seven-cancers.json